Embry Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Embry Holdings heeft een totaal eigen vermogen van HK$2.0B en een totale schuld van HK$267.5M, wat de schuld-eigenvermogensverhouding op 13.2% brengt. De totale activa en totale passiva bedragen respectievelijk HK$2.7B en HK$651.8M.

Belangrijke informatie

13.2%

Verhouding schuld/eigen vermogen

HK$267.50m

Schuld

Rente dekkingsratio	n/a
Contant	HK$227.84m
Aandelen	HK$2.03b
Totaal verplichtingen	HK$651.85m
Totaal activa	HK$2.68b

Recente financiële gezondheidsupdates

Does Embry Holdings (HKG:1388) Have A Healthy Balance Sheet?

Sep 30

Recent updates

Benign Growth For Embry Holdings Limited (HKG:1388) Underpins Its Share Price

Oct 02

Improved Revenues Required Before Embry Holdings Limited (HKG:1388) Shares Find Their Feet

Feb 06

Does Embry Holdings (HKG:1388) Have A Healthy Balance Sheet?

Sep 30

Capital Allocation Trends At Embry Holdings (HKG:1388) Aren't Ideal

Jul 20

Looking For Steady Income For Your Dividend Portfolio? Is Embry Holdings Limited (HKG:1388) A Good Fit?

Mar 21

Our Take On The Returns On Capital At Embry Holdings (HKG:1388)

Feb 21

Would Shareholders Who Purchased Embry Holdings' (HKG:1388) Stock Five Years Be Happy With The Share price Today?

Dec 19

Our Take On The Returns On Capital At Embry Holdings (HKG:1388)

Nov 23

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( HK$811.1M ) 1388 } overtreffen de korte termijn passiva ( HK$364.9M ).

Langlopende schulden: De kortetermijnactiva 1388 ( HK$811.1M ) overtreffen de langetermijnschulden ( HK$286.9M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 2% ) 1388 wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 1388 is de afgelopen 5 jaar gedaald van 22.4% naar 13.2%.

Schuldendekking: De operationele kasstroom van 1388 is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van 1388 op haar schulden goed worden gedekt door EBIT.

Embry Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Does Embry Holdings (HKG:1388) Have A Healthy Balance Sheet?

Recent updates

Benign Growth For Embry Holdings Limited (HKG:1388) Underpins Its Share Price

First half 2024 earnings released: HK$0.20 loss per share (vs HK$0.013 profit in 1H 2023)

Embry Holdings Limited to Report First Half, 2024 Results on Aug 28, 2024

Full year 2023 earnings released: HK$0.17 loss per share (vs HK$0.12 loss in FY 2022)

Embry Holdings Limited, Annual General Meeting, May 23, 2024

Full year 2023 earnings released: HK$0.17 loss per share (vs HK$0.12 loss in FY 2022)

Embry Holdings Limited to Report Fiscal Year 2023 Results on Mar 21, 2024

Improved Revenues Required Before Embry Holdings Limited (HKG:1388) Shares Find Their Feet

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023

First half 2023 earnings released: EPS: HK$0.013 (vs HK$0.003 in 1H 2022)

Embry Holdings Limited to Report First Half, 2023 Results on Aug 24, 2023

Embry Holdings Appoints Mr. Chan Chi on as Director

Full year 2022 earnings released: HK$0.12 loss per share (vs HK$0.065 loss in FY 2021)

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2022

Less than half of directors are independent

Embry Holdings Limited Provides Sales Guidance for the Full Year Ending 31 December 2022

Does Embry Holdings (HKG:1388) Have A Healthy Balance Sheet?

First half 2022 earnings released: EPS: HK$0.003 (vs HK$0.078 in 1H 2021)

Embry Holdings Limited Provides Profit Guidance for Six Months Ended 30 June 2021

Less than half of directors are independent

Embry Holdings Limited Provides Earnings Guidance for the Year Ended December of 2021

Embry Holdings Limited Announces Resignation of Mr. Cheng Man Tai as Executive Director and Chairman, Effective 1 February 2022

Upcoming dividend of HK$0.02 per share

First half 2021 earnings released: EPS HK$0.078 (vs HK$0.092 loss in 1H 2020)

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021

Capital Allocation Trends At Embry Holdings (HKG:1388) Aren't Ideal

Embry Holdings Limited Approves Final Dividend for the Year Ended 31 December 2020

Upcoming dividend of HK$0.025 per share

Embry Holdings Limited Provides Group Financial Guidance for the First Quarter Ended 31 March 2021

Full year 2020 earnings released: HK$0.007 loss per share (vs HK$0.19 profit in FY 2019)

Looking For Steady Income For Your Dividend Portfolio? Is Embry Holdings Limited (HKG:1388) A Good Fit?

Embry Holdings Limited Proposes Final Dividend, Payable on 10 June 2021

Full year 2020 earnings released: HK$0.007 loss per share (vs HK$0.19 profit in FY 2019)

Embry Holdings Limited to Report Fiscal Year 2020 Final Results on Mar 18, 2021

New 90-day high: HK$1.11

Our Take On The Returns On Capital At Embry Holdings (HKG:1388)

New 90-day high: HK$1.05

Would Shareholders Who Purchased Embry Holdings' (HKG:1388) Stock Five Years Be Happy With The Share price Today?

Our Take On The Returns On Capital At Embry Holdings (HKG:1388)

New 90-day low: HK$0.99

New 90-day low: HK$1.00

First half earnings released

Earnings released

Embry Holdings Limited to Report First Half, 2020 Results on Aug 20, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven